Peristent remodeling and neointimal suppression 2 years after polymer-based, paclitaxel-eluting stent implantation: insights from serial intravascular ultrasound analysis in the TAXUS II study.

Peristent remodeling and neointimal suppression 2 years after polymer-based, paclitaxel-eluting stent implantation: insights from serial intravascular ultrasound analysis in the TAXUS II study.

BACKGROUND: The purpose of this study was to evaluate long-term vascular responses as long as 2 years after implantation of polymer-based, paclitaxel-eluting stents in contrast to uncoated stents. METHODS AND RESULTS: TAXUS II is a randomized, double-blind trial comparing slow-release (SR) and mode...

Full description

Bibliographic Details
Main Authors:	Aoki, J, Colombo, A, Dudek, D, Banning, A, Drzewiecki, J, Zmudka, K, Schiele, F, Russell, M, Koglin, J, Serruys, P
Format:	Journal article
Language:	English
Published:	2005

Similar Items

Two-year serial coronary angiographic and intravascular ultrasound analysis of in-stent angiographic late lumen loss and ultrasonic neointimal volume from the TAXUS II trial.
by: Tsuchida, K, et al.
Published: (2007)

Incomplete stent apposition after implantation of paclitaxel-eluting stents or bare metal stents: insights from the randomized TAXUS II trial.
by: Tanabe, K, et al.
Published: (2005)

Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions.
by: Colombo, A, et al.
Published: (2003)

TAXUS VI 2-year follow-up: randomized comparison of polymer-based paclitaxel-eluting with bare metal stents for treatment of long, complex lesions.
by: Grube, E, et al.
Published: (2007)

Final 5-year results of the TAXUS II trial: a randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for de novo coronary artery lesions.
by: Silber, S, et al.
Published: (2009)

Safety and efficacy of multiple, overlapping polymer-based paclitaxel-eluting stents.
by: Dawkins, K, et al.
Published: (2007)

Clinical efficacy of polymer-based paclitaxel-eluting stents in the treatment of complex, long coronary artery lesions from a multicenter, randomized trial: support for the use of drug-eluting stents in contemporary clinical practice.
by: Dawkins, K, et al.
Published: (2005)

TAXUS VI final 5-year results: a multicentre, randomised trial comparing polymer-based moderate-release paclitaxel-eluting stent with a bare metal stent for treatment of long, complex coronary artery lesions.
by: Grube, E, et al.
Published: (2009)

Evaluation of a Targeted Drug‐Eluting Intravascular Nanotherapy to Prevent Neointimal Hyperplasia in an Atherosclerotic Rat Model
by: Emily R. Newton, et al.
Published: (2021-07-01)

Use of a sirolimus-eluting stent to treat failure of a nonpolymer release paclitaxel-eluting stent implanted for in-stent restenosis.
by: Porto, I, et al.
Published: (2005)

Intravascular ultrasound imaging in the diagnosis and treatment of spontaneous coronary dissection with drug-eluting stents.
by: Porto, I, et al.
Published: (2004)

Nanoporous CREG-eluting stent attenuates in-stent neointimal formation in porcine coronary arteries.
by: Jie Deng, et al.
Published: (2013-01-01)

Neointimal healing pattern of a drug-eluting stent in a coronary hematoma
by: Laura Mañas Alonso, et al.
Published: (2019-05-01)

Importance of Short-Term Neointimal Coverage of Drug-Eluting Stents in the Duration of Dual Antiplatelet Therapy
by: Joanna Fluder-Wlodarczyk, et al.
Published: (2024-03-01)

Peristence of triamcinolone crystals after intra-vitreal injection: Benign crystalline hyaloidopathy
by: Rafik Zarifa, et al.
Published: (2013-01-01)

Diabetic and nondiabetic patients with left main and/or 3-vessel coronary artery disease: comparison of outcomes with cardiac surgery and paclitaxel-eluting stents.
by: Banning, A, et al.
Published: (2010)

A meta-analysis of everolimus-eluting stents versus sirolimus-eluting stents and paclitaxel-eluting stents in diabetic patients
by: Hang Ouyang, et al.
Published: (2021-04-01)

Neointimal hyperplasia persists at six months after sirolimus-eluting stent implantation in diabetic porcine
by: Yang ZhenKun, et al.
Published: (2007-06-01)

Neointimal healing pattern of a drug-eluting stent in a coronary hematoma. Case resolution
by: Laura Mañas Alonso, et al.
Published: (2019-05-01)

Update on stents: Recent studies on the TAXUS® stent system in small vessels
by: Shuzou Tanimoto, et al.
Published: (2007-09-01)

The effect of sex differences on neointimal characteristics of in-stent restenosis in drug-eluting stents: An optical coherence tomography study
by: Xiaohang Yuan, et al.
Published: (2023-08-01)

A prospective evaluation of the safety and efficacy of the TAXUS Element paclitaxel-eluting coronary stent system for the treatment of de novo coronary artery lesions: Design and statistical methods of the PERSEUS clinical program
by: Wehrenberg Scott, et al.
Published: (2010-01-01)

Nanofibrous vildagliptin-eluting stents enhance re-endothelialization and reduce neointimal formation in diabetes: in vitro and in vivo
by: Lee CH, et al.
Published: (2019-09-01)

Efficacies of the new Paclitaxel-eluting Coroflex Please™ Stent in percutaneous coronary intervention; comparison of efficacy between Coroflex Please™ and Taxus™ (ECO-PLEASANT) trial: study rationale and design
by: Kim Doo-Il, et al.
Published: (2009-10-01)

Impact of Combination Therapy with Ezetimibe/Simvastatin Treatment on the Neointimal Response to Biodegradable Polymer Biolimus-Eluting Stent Implantation in Patients with Acute Myocardial Infarction: Serial Assessment with Optical Coherence Tomography
by: Yongcheol Kim, et al.
Published: (2018-10-01)

Neointimal healing pattern of a drug-eluting stent in a coronary hematoma. How would I approach it?
by: Santiago Jiménez Valero
Published: (2019-05-01)

Late neointimal volume reduction is observed following biodegradable polymer-based drug eluting stent in porcine model
by: Takeshi Ijichi, et al.
Published: (2021-06-01)

Nanofibrous Vildagliptin-Eluting Stents Enhance Re-Endothelialization And Reduce Neointimal Formation In Diabetes: In Vitro And In Vivo [Corrigendum]
by: Lee CH, et al.
Published: (2019-12-01)

The Interface amongst Conserved and Specialized Pathways in Non-Paclitaxel and Paclitaxel Accumulating <i>Taxus</i> Cultures
by: Michelle C. McKee, et al.
Published: (2021-10-01)

Angiographic and Intravascular Imaging Findings for Ultrasound Detected Aneurysmal Degeneration Following Polymer Based Paclitaxel Eluting Nitinol Stent Implantation for Femoropopliteal Artery Occlusion
by: Tatsuya Nakama, et al.
Published: (2020-01-01)

A randomized multicentre study comparing a paclitaxel drug-eluting balloon with a paclitaxel-eluting stent in small coronary vessels: The BELLO (Balloon Elution and Late Loss Optimization) study
by: Suraj Khanal
Published: (2013-03-01)

Use of Paclitaxel Eluting Stents in Arteriovenous Fistulas: A Pilot Study
by: Krystal Dinh, et al.
Published: (2019-12-01)

Impact of Paclitaxel-Eluting Balloons Compared to Second-Generation Drug-Eluting Stents for of In-Stent Restenosis in a Primarily Acute Coronary Syndrome Population
by: Guillaume Marquis-Gravel, et al.
Published: (2017-09-01)

Clinical outcomes of second-generation limus-eluting stents compared to paclitaxel-eluting stents for acute myocardial infarction with cardiogenic shock.
by: Chun-Tai Mao, et al.
Published: (2019-01-01)

Prophylactic paclitaxel-eluting stent placement does not improve covered femoropopliteal stent patency
by: Rory Marples, MBBS, et al.
Published: (2022-01-01)

Influence of Elongation of Paclitaxel-Eluting Electrospun-Produced Stent Coating on Paclitaxel Release and Transport through the Arterial Wall after Stenting
by: Zhanna K. Nazarkina, et al.
Published: (2021-04-01)

Phacoemulsification for Cataract Secondary to Persistent Hyperplastic Tunica Vasculosa Lentis and Peristent Hyperplastic Primary Vitreous in a Welsh Corgi
by: Mu-Young Kim, et al.
Published: (2018-09-01)

Promoting endothelial recovery and reducing neointimal hyperplasia using sequential-like release of acetylsalicylic acid and paclitaxel-loaded biodegradable stents
by: Lee CH, et al.
Published: (2014-08-01)

Critical evaluation of stents in the peripheral arterial disease of the superficial femoral artery – focus on the paclitaxel eluting stent
by: Litsky J, et al.
Published: (2014-05-01)

Transcriptome and comparative chloroplast genome analysis of Taxus yunnanensis individuals with high and low paclitaxel yield
by: Dong Wang, et al.
Published: (2024-03-01)